molecule,jurisdiction,status,assignee
Pembrolizumab,India,Active,Merck
Pembrolizumab,USA,Active,Merck
Nivolumab,USA,Expired,Bristol Myers Squibb
Atezolizumab,Europe,Active,Roche
Dostarlimab,USA,Active,GSK
Atorvastatin,India,Expired,Pfizer
Pembrolizumab,Europe,Active,Merck
